SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-082907
Filing Date
2020-07-13
Accepted
2020-07-13 07:04:52
Documents
17
Period of Report
2020-07-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2024567-2_8k.htm   iXBRL 8-K 31363
2 EXHIBIT 5.1 tm2024567d2_ex5-1.htm EX-5.1 20691
3 EXHIBIT 10.1 tm2024567d2_ex10-1.htm EX-10.1 189107
7 GRAPHIC tm2024567d2_ex5-1img001.jpg GRAPHIC 5509
8 EXHIBIT 99.1 tm2024567d2_ex99-1.htm EX-99.1 10936
9 GRAPHIC tm2024567d2_ex99-1img001.jpg GRAPHIC 4396
  Complete submission text file 0001104659-20-082907.txt   495886

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bgne-20200712.xsd EX-101.SCH 3183
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bgne-20200712_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bgne-20200712_pre.xml EX-101.PRE 22708
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2024567-2_8k_htm.xml XML 3709
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 201024283
SIC: 2834 Pharmaceutical Preparations